SS

STRATA Skin Sciences IncNASDAQ SSKN Stock Report

Last reporting period 30 Jun, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.013

Micro

Exchange

XNAS - Nasdaq

SSKN Stock Analysis

SS

Uncovered

STRATA Skin Sciences Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-39/100

Low score

Market cap $B

0.013

Dividend yield

Shares outstanding

34.723 B

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 115 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in plastic surgery, developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The firm's XTRAC excimer laser delivers a targeted therapeutic beam of ultraviolet B (UVB) light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. Pharos is its excimer laser device that emits concentrated ultraviolet (UV) light and is used as a tool in the treatment of dermatological skin disorders. VTRAC is a UV light lamp system utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

View Section: Eyestock Rating